Rwanda vs Uzbekistan: HIV-positive TB patients on ART (antiretroviral therapy)
Rwanda
90.0%
in 2024
Uzbekistan
89.0%
in 2023
Rwanda rank
94th
Uzbekistan rank
96th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Rwanda
- Uzbekistan
How they compare
Rwanda currently reports 90.0% against 89.0% in Uzbekistan, a difference of 1.0%.
The two have swapped places 2 times across 18 shared years of data; in 2006 it was Rwanda ahead.
Rwanda ranks 94th and Uzbekistan ranks 96th of 144 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 48.2% | 11.9% | 36.4% | Rwanda |
| 2010s | 84.7% | 56.7% | 28.0% | Rwanda |
| 2020s | 92.8% | 83.0% | 9.8% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Rwanda or Uzbekistan?
- Rwanda, at 90.0% against 89.0% in Uzbekistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Rwanda and Uzbekistan?
- 1.0%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Uzbekistan?
- 18 years are reported by both, from 2006 to 2023.
- How do Rwanda and Uzbekistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Rwanda ranks 94th and Uzbekistan ranks 96th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.